Earn CME: https://naccme.com/program/19-gdugi-3 In this webcast from the ‘Chemotherapeutic Advances in the Treatment of Pancreatic Adenocarcinoma: Improving Outcomes and Treatment Tolerability’ symposium during the 2019 Great Debates & Updates in Gastrointestinal Malignancies conference, Dr. Christopher Crane argues in favor of utilizing conventional radiation therapy for the preoperative treatment of borderline resectable pancreatic cancer. © 2019 Imedex, an HMP Company
Debate: Pre-Op Treatment of Borderline Resectable Pancreatic Cancer – Conventional RT
